Protagonist Therapeutics CEO Dinesh V. Patel disposes of USD 14.89 million in common shares - PTGX News | RalliesProtagonist Therapeutics CEO Dinesh V. Patel disposes of USD 14.89 million in common shares
P
PTGX• CEO sells shares after exercising options
- Protagonist Therapeutics President and CEO Dinesh V. Patel exercised stock options for 100,000 shares at USD 21.58 on Aug. 10-11.
- Patel sold 100,000 shares at weighted average prices of USD 149.11 and USD 148.52 on the same dates.
- Directly held common shares ended unchanged at 523,478.
- Stock options directly held fell to 125,000.
•
